Solutions Rx Pharmacy Recalls Budesonide Capsules Due to Penicillin Contamination
Solutions Rx Pharmacy is recalling compounded budesonide nasal rinse capsules due to possible penicillin cross-contamination in the bulk powder.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, and the hazard involves penicillin contamination, which poses a risk of severe allergic reactions or anaphylaxis in sensitive individuals, meeting the criteria for a Severe rating.
Plain-English summary
Solutions Rx Pharmacy is recalling 11,712 capsules of c-Budesonide 0.6MG, 60-count bottles, intended for use in nasal rinse or nebulizer. The recall is due to the possible presence of penicillin in the bulk budesonide powder used to compound the prescription capsules.
The affected product was distributed in Alabama, Georgia, Tennessee, and Louisiana. The recall covers multiple lots with expiration dates ranging from May 31, 2015, to June 16, 2015.
Consumers should stop using the product and contact their healthcare provider or the recalling pharmacy for instructions on disposal or replacement.
The recalled product
- Product
- c-Budesonide 0.6MG capsules, 60-count bottle, NOT FOR ORAL USE-USE IN NASAL RINSE OR NEBULIZER, SOLUTIONS Rx PHARMACY, 2705 4TH AVENUE SOUTH, BIRMINGHAM, AL 35233
- Manufacturer
- Solutions Rx Pharmacy
- Category
- Drug — Compounded Prescription
- Affected units
- 11,712
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (18)
- Lot #: 04-24-2015-D
- Exp 05/31/15
- 03-13-2015-C
- 03-18-2015-F
- 03-18-2015-G
- 03-23-2015-C
- 03-24-2015-C
- 04-02-2015-G
- 04-14-2015-F
- 04-14-2015-G
- 04-22-2015
- 05-06-2015-B
- 05-14-2015-D
- 05-22-2015-F
- 05-27-2015-C
- 06-02-2015-E
- 06-10-2015-J
- Exp 06/16/15
Distribution
Related recalls
Same hazard · penicillin contamination
See all →- SevereGlaxoSmithKline Recalls Bactroban Nasal Ointment Due to Penicillin Contamination
FDA (Drugs) · 2016-07-27
- SevereGlaxoSmithKline Recalls Bactroban Cream Due to Penicillin Cross Contamination
FDA (Drugs) · 2016-07-27
- SevereGlaxoSmithKline Recalls Bactroban Cream Due to Penicillin Cross Contamination
FDA (Drugs) · 2016-07-27
- SevereLife Science Pharmacy Recalls Compounded Estriol Creams Due to Penicillin Contamination
FDA (Drugs) · 2015-12-09
- SevereLife Science Pharmacy Recalls HCG Injections Due to Penicillin Contamination
FDA (Drugs) · 2015-12-09
Similar recalls
- HighBudesonide inhalation ampules contain black and brown specks and particles
FDA (Drugs) · 2026-06-17
- LowMylan Recalls Budesonide Capsules Due to Dissolution Testing Failures
FDA (Drugs) · 2013-05-29
- SevereMethyfolate Injection Recalled for Potential Penicillin Contamination
FDA (Drugs) · 2015-12-09
- ModerateReliable Compounding Pharmacy Recalls Budesonide Products Due to Processing Control Issues
FDA (Drugs) · 2016-07-13
- SevereLife Science Pharmacy Recalls 2-Deoxy-D-Glucose Powder Due to Penicillin Contamination
FDA (Drugs) · 2015-12-09
- SeverePharm D Solutions Recalls B-Complex Injectable Vials Due to Sterility Concerns
FDA (Drugs) · 2019-06-19